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Abstract
Human papillomaviruses (HPVs) are agents of the most common sexually transmitted diseases in females and males. Precise
data about the presence, mechanism of infection and clinical significance of HPV in the male reproductive tract and
especially in sperm are not available. Here we show that HPV can infect human sperm, it localizes at the equatorial region of
sperm head through interaction between the HPV capsid protein L1 and syndecan-1. Sperm transfected with HPV E6/E7
genes and sperm exposed to HPV L1 capsid protein are capable to penetrate the oocyte and transfer the virus into oocytes,
in which viral genes are then activated and transcribed. These data show that sperm might function as vectors for HPV
transfer into the oocytes, and open new perspectives on the role of HPV infection in males and are particularly intriguing in
relation to assisted reproduction techniques.
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Introduction
Human papillomaviruses (HPVs) comprise a highly diverse
group of small, non-enveloped double-stranded DNA viruses that
belong to the Papillomaviridae family [1,2]. They are agents of the
most common sexually transmitted diseases [3] that can infect
both females and males. HPVs commonly infect mucosal genital
epithelia, with an estimated 75% of humans being affected during
life [4,5]. HPV infection is very common among men and women
across all geographical, racial and socio-economic subgroup
worldwide. More than 100 types of HPV have been identified
and about 40 types infect the anogenital region. Anogenital HPV
types have been further classified into low-risk, which are
associated with anogenital warts and mild dysplasia, and high-
risk types, which are associated with high-grade dysplasia and
anogenital cancers, such as cervical and anal carcinoma [3,6].
In males, HPV DNA and RNA have been well documented not
only in the anal region, perineal area, scrotum, glans, penile shaft,
and urethra [6,7], but also in the reproductive system (testis,
epididymis, and ductus deferens) [7–10]. Moreover, several reports
documented the presence of HPV in the semen [7,11,12]. We
have previously described a 10% prevalence of semen HPV
infection in asymptomatic sexually active young adult men,
showing that HPV can be localized in the sperm head and that
infected spermatozoa had a significant reduction in mean sperm
motility [13]. Moreover, we have recently demonstrated a higher
prevalence of infection in the semen of patients with risk factors for
HPV (patients with genital warts and partners of infected females)
than in controls [14].
However, precise data about the presence and significance of
HPV in sperm are not available. In particular, the exact
localization and mechanism of infection by HPV in sperm, as
well as the role of infected sperm cells as a transmission vector for
the virus are still unknown. It is not known whether HPV-infected
sperm are able to infect the partner and whether they are able to
fertilize. This is also of crucial importance in relation to in vitro
fertilization techniques because of the possibility that sperm
infected with HPV injected in the oocyte cytoplasm (like during
the intra-cytoplasmic sperm injection procedure) could interfere
with fertilization, implantation, embryo development, premature
abortion, and definitively with outcome and safety of assisted
reproduction techniques (ART). Infertile patients seeking ART are
at higher risk to carry HPV in sperm (10% with respect to 0% of
fertile controls) [14] and HPV has been demonstrated in about 6%
of sperm samples cryopreserved from testicular cancer patients
[15], who need ICSI to become father.
In this study we aimed at better understand the mechanism of
infection by HPV in human sperm and the ability of HPV-infected
sperm to fertilize and transfer HPV DNA and capsid proteins to
the oocyte. We used different in vitro methods to localize HPV
DNA in sperm and to show the interaction between the capsid
protein L1 and the primary attachment receptor syndecan-1 on
sperm. Then, we used the hamster egg-human sperm penetration
test to show the ability of sperm to transfer the capsid protein L1 to
PLoS ONE | www.plosone.org 1 March 2011 | Volume 6 | Issue 3 | e15036the oocyte and the transfer of E6/E7 viral genes to the oocyte by
transfected sperm and the expression of these genes by the oocyte.
Results and Discussion
Human sperm from a male previously found to carry HPV16 in
semen [13] were studied by fluorescence in situ hybridization
(FISH) using biotin-labeled HPV DNA probe (a mix of total
genomes containing the conserved HPV region) and visualized by
fluorescence microscope (Fig. 1a). A clear signal was found in
about 25% of sperm and the fluorescence was evident in the sperm
head. To confirm this analysis and better understand the precise
localization in the sperm head, we performed immunofluorescence
analysis using an antibody against the capsid protein L1 in intact
sperm and sperm which underwent acrosome reaction (Fig. 1b).
The signal for L1 was confirmed to be exclusively localized in the
sperm head, especially at the equatorial region. After acrosome
reaction the signal persisted in this region, excluding therefore the
presence of HPV in the acrosome and suggesting a preferential
localization of HPV in the equatorial region. PCR analysis for the
L1 gene confirmed the infection of sperm by HPV (Fig. 1c). Taken
together, these data show that sperm might be infected by HPV
and that both HPV DNA and L1 capsid protein are found in the
sperm head, almost exclusively in the equatorial region.
Cell entry of HPV is initiated by binding of the virus particle to
cell surface receptors, a prerequisite for subsequent interaction
with the elusive uptake receptor, internalization and deliver of the
genetic material into the nucleus of the target cell [16–19]. The
HPV genome is surrounded by an icosahedral capsid composed by
two structural proteins, the major protein L1 and the minor capsid
protein L2 [18,20]. Initial binding to the cell surface is mediated
by L1 that interacts with heparan sulfate proteoglycans (HSPGs),
followed by conformational changes and proteolytic cleavage of L2
that is essential for successful infection [16,19]. Among HSPGs,
syndecan-1 seems to represent the primary attachment receptor
[16,19,21–25]. Syndecan-1 is a widely expressed membrane-
bound proteoglycan found predominantly in the epithelial cells
[26], but no information exists about its possible presence in
sperm. To test the hypothesis that HPV infects sperm by binding
with syndecan-1, we performed flow cytometric and immunoflu-
orescence analyses of native sperm and sperm exposed to HPV16
capsid (Fig. 2). These analyses showed that sperm express
syndecan-1 most exclusively in the equatorial region of sperm
head (Fig. 2b) and both flow cytometry and immunofluorescence
were blocked by the use of heparinase III (Fig. 2a and 2b),
confirming the specificity of the reaction. To analyze whether
HPV interacts with syndecan-1, sperm were exposed to HPV16
L1 capsid protein and then treated with heparinase III.
Cytofluorimetric and immunofluorescence analyses showed that
treatment with Heparinase III abolished the binding of HPV to
sperm (Fig. 2c and 2d). Furthermore, immunofluorescence analysis
showed that HPV16 L1 protein and syndecan-1 colocalize in the
equatorial region of sperm head, and the binding was completely
abolished by treatment of sperm with Heparinase III (Fig. 2e).
These data clearly show that HPV infection of human sperm
implies attachment of the HPV capsid protein L1 to syndecan-1 in
the equatorial region of sperm head.
We then studied the fertilizing ability of HPV infected sperm
and the possible transfer of the virus into oocytes. To this aim we
used the hamster egg-human sperm penetration test (HEPT) using
sperm transfected with a plasmid containing the HPV genes E6/
E7 linked to GFP and using sperm exposed to the HPV capsid
protein L1. The E6/E7 genes were amplified from plasmid p1321
HPV-16 E6/E7 and subcloned into plasmid pIRES-AcGFP1 to
construct recombinant plasmid pIRES-AcGFP1-E6E7 (Fig. 3a),
which was then used to transfect human sperm. After confirmation
of successful transfection, HEPT demonstrated that human sperm
transfected with HPV E6/E7 genes were able to penetrate
hamster oocytes, even if the mean number of sperm penetrated
per oocyte was lower than that obtained with control sperm
(Fig. 3c). SYBR green staining for DNA confirmed the successful
penetration of oocytes by transfected sperm (Fig. 3d). The
Figure 1. Detection and localization of HPV in human sperm. a. Fluorescence in situ hybridization (fluorescence microscope) for HPV DNA on
sperm from a patient with HPV16 in semen. Infected and noninfected sperm are shown. Red: HPV DNA (Texas red); blue: nuclear staining (DAPI).
b. Immunofluorescence (confocal fluorescence microscope) for HPV16 capsid protein L1 on sperm from a control (left) and a patient with HPV16 in
semen (right). Upper panel, L1 antibody; central panel, L1 antibody and Pisum Sativum (acrosome); lower panel, L1 antibody and Pisum Sativum after
induction of the acrosome reaction. Red: HPV16 L1; green: Pisum Sativum; blue: nuclear staining (DAPI). c. PCR for HPV E7 gene from sperm DNA.
Lane M: DNA marker (100 bp); 1: negative control (no template); 2: positive control (sperm transfected with recombinant plasmid pIRES2-AcGFP1-
E6E7); 3: sperm from a patient with HPV16 in semen; 4: sperm from a control subject.
doi:10.1371/journal.pone.0015036.g001
HPV and Human Sperm
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on single oocytes (Fig. 4a). Then, we analyzed whether oocytes
penetrated by sperm transfected with HPV E6/E7 express the
viral genes. Since the E6/E7 genes were linked to GFP in the
plasmid, oocytes penetrated by transfected sperm had a green
fluorescence if E6/E7 genes were transcribed. This analysis
showed that oocytes express GFP when HPV transfected sperm
penetrated (Fig. 4c), suggesting an active transcription of E6/E7
genes by the oocyte. This finding was confirmed by RT-PCR for
the E6 gene performed on single oocytes with green fluorescence
(Fig. 4d). Taken together these data showed that sperm transfected
with E6/E7 genes are able to penetrate the oocyte, to deliver HPV
genome in the oocyte, and that HPV genes are then actively
transcribed by the penetrated oocyte. However, these data might
not truly reflect the in vivo situation because the use of transfected
sperm is obviously an artificial condition. Therefore, we performed
HEPT with sperm exposed to HPV L1 capsid protein and we
found that sperm are able to transfer the L1 protein into the
oocyte (Fig. 5).
Taken together, the findings of the present study show that
sperm might be infected by HPV and that the mechanism of entry
of the virus in the sperm is mediated by interaction of the HPV L1
capsid protein with syndecan-1 that is mainly localized in the
equatorial region of the sperm head. Other viruses found in
association with sperm, such as HIV and HSV, have been shown
to interact with HSPGs [27–31], suggesting this mechanism is a
general strategy used by sexually transmitted viruses to infect
sperm and overcome long distances and mucus barriers in the
female genital tract. More interestingly, we were able to show that
both sperm transfected with HPV E6/E7 genes and sperm
exposed to HPV L1 capsid protein are capable to penetrate the
oocyte, but this fertilization process seems to be impaired.
Anyway, sperm might function as vectors for HPV transfer into
the oocytes, as both L1 protein and E6/E7 ‘‘transforming’’ genes
Figure 2. HPV interacts with syndecan-1 on human sperm. a. Cytofluorimetric analysis with mouse anti-human CD138 (syndecan-1), FITC
conjugated on sperm before and after treatment with Heparinase-III. Samples without anti CD138 were used as negative controls. b.
Immunofluorescence analysis (confocal fluorescence microscope) for syndecan-1 (CD138, FITC conjugated of sperm before and after treatment with
Heparinase-III. Upper panel: negative control (omission of CD138); central panel: syndecan-1; lower panel: syndecan-1 after Heparinase-III treatment.
c. Cytofluorimetric analysis of sperm exposed to HPV16 L1 capsid protein, treated or not with Heparinase-III and analyzed with mouse monoclonal
HPV16 L1 antibody. Samples incubated with secondary phycoerythrin anti-mouse antibody alone were used as negative controls. d.
Immunofluorescence analysis for HPV L1 capsid protein (confocal fluorescence microscope) in sperm exposed to HPV16 L1 treated or not with
Heparinase-III and analyzed with mouse monoclonal antibody anti HPV16 L1 and DAPI. e. Colocalization analysis of HPV L1 capsid protein and
syndecan-1 by immunofluorescence (confocal fluorescence microscope) of sperm exposed to HPV16 L1 treated or not with Heparinase-III and
analyzed with mouse anti-human CD138 (syndecan-1) monoclonal antibody, FITC conjugated and mouse monoclonal antibody anti HPV16 L1 and
DAPI.
doi:10.1371/journal.pone.0015036.g002
HPV and Human Sperm
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of the oocytes are then activated and transcribed.
These findings confirm previous studies that showed that
HPV16 capsids bind at the equatorial region of the sperm head
[32], but highlight for the first time the mechanism of interaction
between HPV and sperm and the delivery and activation of HPV
genome into the oocyte during natural fertilization. Previous
studies [33,34] showed that incubation with HPV is able to
transfer viral DNA into sperm and that the infected cells can
deliver exogenous DNA to the cumulus cells surrounding ovulated
oocytes at the time of fertilization. It is not known whether there
are risks for the partners of an HPV-infected male or for the
embryos fertilized by infected sperm. Anyway, our data suggest
that HPV-infected sperm have lower fertilizing ability, and these
findings are particularly important during ART procedures.
Furthermore, we recently demonstrated that HPV-infected sperm
have reduced motility, and a possible role for HPV semen
infection has been suggested for male infertility related to altered
sperm motility (asthenozoospermia) [13,14]. Although further
studies are necessary to better understand the possible clinical
implications of the findings of the present study, these data open
new perspectives on the role of HPV infection in males.
Methods
Ethics Statement
The study was approved by the Institutional Ethics Committee
of the Hospital of Padova and written informed consent was
provided by participants.
Semen sample collection and preparation
Human semen samples from volunteers were obtained by
masturbation after 2–5 days of sexual abstinence in sterile
containers. Samples were allowed to liquefy for 30 minutes at
room temperature and semen volume, pH, sperm concentration,
viability, motility, and morphology were determined following
World Health Organization guidelines for semen analysis [35].
Sperm were separated by washing semen three times with
Modified HTF medium with human serum albumin 5 mg/ml
(Sperm washing medium, Irvine Scientific, Santa Ana, CA) and
centrifuged at 300 g for 10 minutes. The pellet was used to collect
the spermatozoa after swim-up technique (500 ml of sperm
washing medium was layered gently up to the pellet, the tube
was slanted to 45u and incubated for 1 h at 37uC in a 5% CO2
incubator), the collected spermatozoa were used for subsequent
Figure 3. Sperm transfected with E6/E7 plasmid penetrate oocytes. a. Scheme of the recombinant plasmid pIRES2-AcGFP1-E6E7. E6/E7
genes have been amplified (1032 bp) from plasmid p1321 HPV-16 E6/E7 by PCR and subcloned to plasmid pIRES2-AcGFP1 between SalI and BamHI
restriction sites. b. PCR for HPV E6/E7 genes from transfected sperm. Lane M: DNA marker (100 bp); 1: sperm transfected with recombinant E6/E7
plasmid; 2: negative control (no template); 3: sperm transfected only with Lipofectamine 2000; 4: positive control (pIRES2-AcGFP1-E6E7 plasmid).
c. Mean number of human sperm penetrated per hamster oocyte in control and sperm transfected with HPV-16 E6/E7 plasmid. d. Hamster oocytes
penetrated by control sperm and sperm transfected with HPV16 E6/E7 plasmid in bright field (BF, upper panel) and fluorescence (FL, lower panel)
using SYBR green DNA stain.
doi:10.1371/journal.pone.0015036.g003
HPV and Human Sperm
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were investigated for HPV identification and localization (HPV
DNA, HPV16-L1 capsid), by fluorescence in situ hybridization,
immunofluorescence and PCR as described below.
Fluorescence in Situ Hybridization (FISH) for HPV in
human sperm
Sperm samples containing at least 2610
6 sperm were fixed in a
methanol-acetic acid solution for at least 1 hour at 220uC. To
permeabilize sperm membrane, samples were treated with pepsin
(1:25,000, 0.01 mol/L) in prewarmed HCl 1 mol. for 10 minutes
at 37uC. Permeabilization of the specimens was stopped with
4 min. washes in PBS 16. Samples were then dehydrated in 70%,
80%, and absolute ethanol for 2 minutes and finally air-dried.
Samples were then overlaid with 20 mL of hybridization solution
containing biotin (BIO)-labeled HPV DNA probe (a mix of total
genomes 7–8 Kb, containing the conserved HPV region) (Re-
mbrandt in situ hybridization and detection kit HPV, Pan Path,
Amsterdam, Netherlands). Each slide was covered with a glass
coverslip and the edges were sealed with nail polish to prevent loss
of the mixture during denaturation and hybridization. After
denaturation of cellular target DNA and HPV DNA probe on a
heating block for 5 min. at 95uC, hybridization was performed by
incubating the samples at 37uC overnight in a humidified
chamber. Thereafter, the coverslips were carefully removed and
the slides were washed in PBS 16 for 10 minutes. After
15 minutes of incubation at 37uC with a wash solution to
eliminate non-specific bound probe for use in situ hybridization
(ISH) (R013R.0000 Pan Path, Amsterdam, Netherlands), the slides
were washed three times in PBS 16for 3 minutes. The negative
control was processed in the same way, but omitting the viral
probe. The biotin-labeled HPV probe was detected by incubation
with 1:200 streptavidin Texas red (Vector Laboratories, Burlin-
game, CA) for 40 minutes at room temperature. After detection,
the slides were washed twice in PBS 16/0.01% Triton and then
twice in PBS 16 and mounted with a solution containing 4,6-
diamino-2-phenylindole (DAPI 5 mg/mL) and antifade (BioBlue;
BioView, Nes Ziona, Israel). Samples were analyzed using a
fluorescence microscope (Nikon, Eclipse E600, Melville, NY,
USA) equipped with a triple band-pass filter set (fluorescein
Figure 4. Oocytes penetrated by sperm transfected with HPV E6/E7 express HPV E6/E7 genes. a. PCR for E6 gene from single oocyte
penetrated by transfected sperm. Lane M: DNA marker (100 bp); 1: positive control (pIRES2-AcGFP1-E6E7 plasmid); 2: single oocyte penetrated by
sperm transfected with recombinant plasmid; 3: negative control (no template); 4: single oocyte penetrated by sperm transfected only with
Lipofectamine 2000. b. GFP-E6 expression in oocyte penetrated by control sperm. c. GFP-E6 expression in oocyte penetrated by transfected sperm.
d. RT-PCR for E6 gene from single oocyte penetrated by transfected sperm. Lane M: DNA markers (100 bp); 1: negative control (no template for
Reverse Transcription); 2: negative control (no template for PCR); 3: single oocyte with green fluorescence penetrated by transfected sperm; 4: single
oocyte without green fluorescence penetrated by control sperm.
doi:10.1371/journal.pone.0015036.g004
HPV and Human Sperm
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DAPI). For each slide 200 spermatozoa were analyzed. When
nuclei were completely and homogeneously stained and when
multiple small spots or single large signals were present, the sperm
cells were classified as positive. The method was tested on control
slides containing CaSki cells (R013R.0000 Pan Path, Amsterdam,
Netherlands), human cervical carcinoma cell line with stably
integrated and transcriptionally active HPV genomes that served
as control for the specific probe.
Immunofluorescence for HPV16-L1 capsid protein in
human sperm
Sperm were resuspended at a concentration of 20610
6 sperm/mL
in sperm washing medium and incubated with 20 mg/ml HPV16-L1
(Gardasil, Sanofi Pasteur MSD, Lyon, France) for 1 h at 37uC. The
reaction volume was 300 mL. After incubation, motile spermatozoa
were harvested by the swim-up technique as described above. The
swim-up sperm fraction was divided in two samples used for later
HPV16-L1 capsid detection after or not induction of acrosome
reaction by calcium Ionophore III (Sigma-Aldrich) at 10 mM. Sperm
without incubation with HPV16-L1 were used as negative control.
For immunofluorescence, 10 ml of sperm sample was smeared
on clean, grease-free slides, air-dried, and fixed in PBS/
paraformaldehyde 4% for 15 minutes. The glasses were washed
three times in PBS for 5 minutes at room temperature and then
used for the HPV capsid (HPV16-L1) and acrosome (pisum
sativum) detection.
For HPV16-L1 detection the sperm were incubated with mouse
monoclonal antibody HPV 16-L1 (CAMVIR-1) (0.8 mg/mL,
1:250, Santacruz, Santa Cruz, CA) for 120 minutes at room
temperature, and then washed in 0.2% tween-PBS for 5 minutes.
Immunoreaction was detected by sequential incubation with
biotinylated goat anti-mouse immunoglobulin secondary antibody
(1:200, Vector Laboratories, Burlingame, CA) and streptavidin
Texas red (1:400, Vector Laboratories, Burlingame, CA) both for
60 minutes at room temperature. After that the slides were
incubated with the acrosome specific Pisum Sativum (1 mg/ml) for
30 minutes at room temperature and then washed twice in PBS.
Nuclei were counterstained with DAPI 5 mg/mL, slides were
mounted with anti-fade buffer and 24624 mm coverslip. Immu-
nostaining was evaluated with Nikon ViCo Video Confocal
Microscope.
HPV DNA (L1 gene) detection in human sperm
DNA extraction from swim-upped sperm was performed by
QIAamp DNA mini kit (Qiagen, Valencia, CA). The presence of
HPV DNA sequence (L1 gene) was investigated by nested
polymerase chain reaction (PCR) using MY09/MY11 as outer
primers and GP5/GP6 as inner primers. The amplification
products were analyzed by staining with SYBR safe DNA gel
stain, after electrophoresis on 2% agarose gel. PCR amplification
was carried also with a positive control (sperm transfected with
recombinant plasmid pIRES2-AcGFP1-E6E7, see below) and a
negative control (no template).
Figure 5. Transfer of HPV L1 capsid protein from human sperm to hamster oocytes. Immunofluorescence (confocal fluorescence
microscope) for HPV16 L1 on hamster oocytes penetrated by human sperm exposed to HPV L1. Upper panel: oocytes penetrated by control sperm;
lower panel: oocytes penetrated by sperm exposed to L1. Left; nuclear staining with DAPI (blue); right: HPV L1 antibody (green).
doi:10.1371/journal.pone.0015036.g005
HPV and Human Sperm
PLoS ONE | www.plosone.org 6 March 2011 | Volume 6 | Issue 3 | e15036Flow cytometry and immunofluorescence for CD138
(Syndecan-1) and HPV16-L1 capsid protein on human
sperm
To evaluate the interaction between syndecan-1 and HPV16
capsid, fresh spermatozoa were washed twice in sperm washing
medium and centrifuged (300 g for 10 minutes). The pellet was
resuspended in PBS and divided into two aliquots with 40610
6
sperm cells with and without incubation with 3.5 U/ml Hepari-
nase-III (Sigma Aldrich, St. Louis, MO) for 60 minutes at 37uC.
Sperm were incubated with HPV16-L1 protein (20610
6 sperm/
mL were resuspended in sperm washing medium and incubated
with 20 mg/ml HPV16-L1 protein for 1 h at 37uC).
To detect CD138 (Syndecan-1) and HPV16-L1 in cytofluori-
metry sperm were incubated with mouse anti-human CD138
monoclonal antibody, FITC conjugated, clone 1D4 (1:5, Biole-
gend, San Diego, CA) or with mouse monoclonal antibody
HPV16-L1 (CAMVIR-1) (1 mg/mL) (1:200, Santacruz, Santa
Cruz, CA) both on ice for 45 minutes in the dark. Sperm were
washed twice in phosphate-buffered saline (PBS) and centrifuged
at 300 g for 5 minutes. For HPV16-L1, the second layer
phycoerythrin anti-mouse antibody (PE, 10 mM, Becton Dick-
inson, Franklin Lakes, NJ) was added to the cells and incubated for
45 minutes on ice. A multiple myeloma cell line U266 (ATCC,
Manassas, VA, USA) were used as positive controls for syndecan-
1, and the samples incubated with secondary antibody alone were
used as negative controls for HPV16-L1. Samples were washed
twice in PBS and centrifuged at 300 g for 5 minutes. The pellet
was resuspended in 300 ml of PBS and then analyzed on a
FACScalibur (Becton Dickinson, Oxford, UK) using Cellquest to
acquire and analyze the data.
To detect CD138 (Syndecan-1) and HPV16-L1 colocalization
in immunofluorescence, 10 ml of sperm samples were smeared on
clean, grease-free slides, air-dried, and fixed in PBS/paraformal-
dehyde 4% for 15 minutes. The glasses were washed three times in
PBS for 5 minutes, incubated with mouse anti-human CD138
monoclonal antibody, FITC conjugated, clone 1D4 (1:10,
Biolegend, San Diego, CA) overnight at 4uC, washed twice in
PBS and incubated with mouse monoclonal antibody HPV 16-L1
(CAMVIR-1) (1:250, 0.8 mg/mL, Santacruz, Santa Cruz, CA) for
120 minutes at room temperature. The slides were washed twice
in 0.2% tween-PBS for 5 minutes. Immunoreaction for the
HPV16-L1 was detected by sequential incubation with biotiny-
lated goat anti-mouse immunoglobulin secondary antibody (1:200
from Vector Laboratories, Burlingame, CA) and streptavidin
Texas red (1:400, Vector Laboratories, Burlingame, CA) both for
60 minutes at room temperature. The slides were washed twice in
PBS, and nuclei were counterstained with (DAPI 5 mg/mL).
Slides were mounted with anti-fade buffer and 24624 mm
coverslip. Immunostaining was evaluated with Nikon ViCo Video
Confocal Microscope. Sperm without incubation with CD138
(Syndecan-1) and HPV16-L1 were used as negative control.
Construction of recombinant plasmid pIRES2-AcGFP1-
E6E7
The expression vector for HPV E6/E7 genes and GFP was
constructed as Figure 3a. The E6/E7 genes were amplified
(1032 bp) from plasmid p1321 HPV-16 E6/E7 (Clontech,
Mountain View, CA) by PCR and subcloned into plasmid
pIRES2-AcGFP1 (Clontech, Mountain View, CA) to construct
recombinant plasmid pIRES2-AcGFP1-E6E7. The PCR mixture
consisted of 5 mL Expand high fidelity buffer with MgCl2,1mLo f
PCR grade nucleotide mix (106), 20 pmol of each primer with
SalI and BamHI restriction sites (New England Biolabs, Ipswich,
MA) including forward: 59-GTGCGCGTCGACGTGATGCAC-
CAAAAGAGAACTG-39 and reverse: 59-GTGCGCGGATCC-
GTGTGGTTTCTGAGAACAGATG-39, 0,75 mL Expand high
fidelity enzyme mix (Expand High Fidelity PCR System dNTPack,
Roche Applied Science, Mannheim, Germany) and sterile H2Oi n
a final volume of 50 mL. The amplification program was as
follows: denaturing at 94uC for 2 minutes, 10 cycles each at 94uC
for 15 seconds, annealing at 55uC for 30 seconds and extension at
72uC for 1 minute, 20 cycles each at 94uC for 15 seconds,
annealing at 55uC for 30 seconds and extension at 72uC for
1 minute plus 5 seconds cycle elongation for each successive cycle,
followed by a final extension at 72uC for 7 minutes. The
amplification products were analyzed by staining with SYBR safe
DNA gel stain, after electrophoresis on 1% agarose gel and then
purified using Microcon YM-100 (Millipore Corporation, Bed-
ford, MA). Then the purified amplification products and plasmid
pIRES2-AcGFP1 were digested by restriction enzyme SalI and
BamHI (10 U at 37uC for 120 minutes). These digested PCR
products were purified from a 0.8% agarose gel using the S.N.A.P.
Gel Purification Kit (Invitrogen, Paisley, UK), according to the
manufacturer’s protocol. The purified PCR products and plasmid
pIRES2-AcGFP1 were analyzed on a second 0.8% agarose gel to
confirm recovery. Finally, these purified PCR products were
recombined into plasmid pIRES2-AcGFP1 using T4 DNA ligase
kit (New England Biolabs, Ipswich, MA) and subjected transfor-
mation into E. coli DH5a (Invitrogen, Paisley, UK) according to
manufacturer instruction. The successful construction was con-
firmed by PCR, BamHI, and Sal I digestion and DNA sequencing.
Transfection of human sperm with plasmid pIRES2-
AcGFP1-E6E7
Motile sperm were harvested by the swim-up technique as
described above. The swim-up sperm fraction was divided in four
samples: one used for the transfection with plasmid pIRES2-
AcGFP1-E6E7, the second one used for the transfection with 2 mL
Lipofectamine 2000 alone (Invitrogen, Paisley, UK), the third one
used for the transfection with plasmid pIRES2-AcGFP1 and the
last one as negative control.
Sperm were incubated in BWW supplemented with HEPES
(10 mM, pH 7.4) and 3.5 mg/ml HSA (Human Serum Albumin)
for capacitation at 37uC and 5% CO2 for 4 hours. Three hours
after the beginning of capacitation, sperm were exposed to plasmid
pIRES2-AcGFP1-E6E7. Briefly, a total of 100 mL mixture
containing 800 ng plasmid pIRES2-AcGFP1-E6E7 and 2 mL
Lipofectamine 2000 (Invitrogen, Paisley, UK) in BWW was
incubated at room temperature for 20 minutes, and then was
added to sperm sample and kept in the incubator for another
1 hour. After that, the sperm sample was washed at least five times
in 5 mL of fresh BWW.
The successful of human sperm transfection with plasmid
pIRES2-AcGFP1-E6E7 was confirmed by PCR. The DNA was
extracted from sperm by QIAamp DNA Mini Kit (Qiagen,
Valencia, CA), according to the manufacturer’s protocol. Plasmid
pIRES2-AcGFP1-E6E7 and sterile ddH2Ow e r eu s e da st h e
positive and negative controls, respectively. The PCR mixture
consisted of 5 mL1 0 6 TaqGold buffer, 3 mL of MgCl2 25 mM,
5 mLofeachdeoxynucleosidetriphosphate 200 mmol/L, 20 pmol of
each primer (forward CMV: 59-CGCAAATGGGCGG-
TAGGCGTG-39 and reverse IRES: 59-CCTCACATTGC-
CAAAAGACG-39), 2.5 U TaqGold polymerase and sterile H2O
in a final volume of 50 mL. The amplification program was as
follows: denaturing at 94uC for 10 minutes, 37 cycles each at 94uC
for 1 minute, annealingat 55uC for1 minuteand extension at 72uC
for 2 minutes, followed by a final extension at 72uC for 10 minutes.
HPV and Human Sperm
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safe DNA gel stain, after electrophoresis on 1% agarose gel.
Hamster Egg Penetration Test (HEPT) with human sperm
transfected with HPV E6/E7 plasmid
The HEPT was performed according to the World Health
Organization [35] criteria with the use of commercially available
frozen hamster eggs (Charles Rivers Laboratories, Wilmington,
MA, USA) with human sperm transfected or not with plasmid
pIRES2-AcGFP1-E6E7. After thawing, 120 eggs were washed
three times in BWW and transferred to 0.1% trypsin to remove the
zona pellucida. The zona-free hamster eggs were washed three
timesinBWW.Then,15eggswere placedin100 mLcontaining10
6
motile spermatozoa under mineral oil. After 3 hours incubation at
37uC in a 5% CO2 atmosphere oocytes were recovered from the
droplets and washed to loose adherent spermatozoa. To evaluate
the successful sperm penetration, 40 oocytes (10 for each condition)
were analyzed with the nuclear acid staining SYBRGreen
(Invitrogen, Paisley, UK) under phase contrast microscopy and
under the fluorescence microscope at 4006magnifications (Leica
DMLB, Wetzlar, Germany). Sperm egg penetration test was
expressed as mean number of sperm penetrated for oocyte (HSA).
Twenty-four hours after insemination, the remaining oocytes were
investigated under the fluorescence microscope (Leica DMLB,
Wetzlar, Germany) at 4006 magnifications. The oocytes were
collected and classified into two groups: oocytes with green
fluorescence and oocytes without green fluorescence. The oocytes
from two groups were washedthreetimes incold 16PBStoremove
serumfromthemediumandtheneach oocytewastransferredsingly
into a PCR tube for PCR and RT-PCR.
Single-Oocyte PCR for E6E7 genes
5 mL of cell lysis buffer were added to each oocyte, mixed then
incubated at 65uC for 10 minutes. The cell lysate of oocyte was
used as a DNA template. Plasmid pIRES2-AcGFP1-E6E7 and
sterile ddH2O as the positive and negative controls, respectively.
The first round multiplex PCR was performed with mixture
consisted of 5 mL1 0 6 TaqGold buffer, 3 mL of MgCl2 25 mM,
5 mL of each deoxynucleosidetriphosphate 200 mmol/L, 20 pmol
of each primer (forward CMV: 59-CGCAAATGGGCGG-
TAGGCGTG-39 and reverse IRES: 59-CCTCACATTGC-
CAAAAGACG-39), 2.5 U TaqGold polymerase and sterile H2O
in a final volume of 50 mL. The amplification program was as
follows: denaturing at 94uC for 10 minutes, 37 cycles each at 94uC
for 1 minute, annealing at 55uC for 1 minute and extension at
72uC for 2 minutes, followed by a final extension at 72uC for
10 minutes. This first round multiplex PCR is followed by a nested
PCR reaction with one of the same outer primer (forward CMV)
combined with a unique inner primer (reverse: 59-GCA-
TAAATCCCGAAAAGCAA-39). The amplification products
were routinely analyzed by staining with SYBR safe DNA gel
stain, after electrophoresis on 1,5% agarose gel.
Single-Oocyte RT-PCR for E6/E7 expression
RNA extraction from each oocyte followed by RT-PCR was
performed using the cells-to-cDNA II kit (Ambion, Austin, Texas).
10 mL of cold cell lysis buffer II were added to each oocyte, and
incubated at 75uC for 10 minutes. 0.12 U DNase I was added to
the mixture at 37uC for 30 minutes. Reverse transcription was
preformed according to the kit protocol. PCR amplification was
carried out with 10 mL cDNA of each sample from reverse
transcription reaction as a template, E6/E7 specific primer pair
(forward: 59-GTCGACGTGATGCACCAAAAGAGAACTG-39
and reverse: 59- GCATAAATCCCGAAAAGCAA-39) and two
negative controls (no template and no reverse transcription). The
amplification step was carried out using these conditions:
denaturing at 94uC for 10 minutes, 37 cycles each at 94uC for
1 minute, annealing at 55uC for 1 minute and extension at 72uC
for 1 minute, followed by a final extension at 72uC for 10 minutes.
About 20 mL of each PCR product were made visible by staining
with SYBR safe after electrophoresis on 1.5% agarose gel. This
experiment was repeated three times under the same condition.
Immunofluorescence of oocytes after penetration of
human sperm incubated with HPV16-L1
The sperm were incubated or not with HPV16-L1 20 mg/ml and
then were selected by swim-up for 45 minutes at 37uC, capacitated
for 3 hours, and washed in BWW. Both samples were resuspended
in fresh medium and the concentration of motile sperm was
adjusted to 5 mil/mL. Meanwhile, the oocytes were prepared as
described before. Fifteen eggs were placed in 100 mL containing 10
6
motile sperm under mineral oil. After 3 hours of incubation at 37uC
in a 5% CO2 atmosphere, oocytes were recovered from the
droplets, washed free of loosely adherent spermatozoa. To perform
immunofluorescence for HPV16-L1 in penetrated oocytes, samples
were washed three times in BWW, allowed to air dry, fixed in PBS/
paraformaldehyde 4% for 15 min and permeabilized with 3%
PBS/Triton 6100 for 5 min (Sigma Aldrich, St. Louis, MO) at
room temperature. All oocyte were then incubated with mouse
monoclonal antibody HPV 16-L1 (CAMVIR-1) (0.8 mg/mL)
(1:250, Santacruz, Santa Cruz, CA) for 120 minutes at room
temperature. Immunoreaction was then detected by sequential
incubation with FITC-anti-IgG mouse secondary antibody (1:200
from Bio-Rad, Berkeley, CA) for 60 minutes at room temperature.
The slides were washed twice in PBS, and nuclei were counter-
stained with DAPI (5 mg/mL). Slides were mounted with anti-fade
bufferand24624 mmcoverslip.Finally,the oocyteswereplacedon
to the slides and the immunostaining was evaluated with Nikon
ViCo Video Confocal Microscope.
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